Investor Development Group - Fusion Pharm Inc.

FOR IMMEDIATE RELEASE
New York, New York, United States of America (Free-Press-Release.com) September 7, 2011 -- INVESTMENT OPPORTUNITIES

The Medical Cannabis industry during recent years has had scientists and medical doctors – as well as their own patients and groups dedicated to legalizing marijuana for medical use – they have made headway, and now medical cannabis is officially sanctioned in 15 states and Washington DC.

1

Investor Development Group - Fusion Pharm Inc.

Welcome visit Our WebSite:

http://www.marketreturn.us

Medical Cannabis works well for treatment of chronic pain, treatment of glaucoma, and other maladies. Because of the increase in popularity of marijuana as a medical drug, many companies are hoping to profit from this industry, by growing, distributing, infusing marijuana to consumers who need it as a medication.

By buying stock in companies that are positioned to benefit from the future of medical cannabis, you can get in on the ground floor of any potential breakthrough in this biotech and healthcare sector. We invest in companies that are already profitable selling Medical Cannabis. If marijuana research convinces legislators to allow it to be sold like ordinary medicine, these companies will surely get a piece of the action just by being in the game early.

By investing in FusionPharm, Inc. , you will benefit immediately. The future is bright for medical cannabis and you’ll be positioned to take full advantage of the new and revolutionary products. FusionPharm, Inc. is looking for investors who are interested in the Medical Cannabis Industry as a nationwide business model. FusionPharm, Inc. is a publically traded company that will be a leader in Medical Cannabis Business investments. Please follow our stock as it grows, our stock symbol is FSPM.

More information can be found online at http://www.marketreturn.us

Chronic Pain Medication     glaucoma     Hot penny stocks     investment opportunity     Marijuana Dispensary     medical cannabis     revenues     stock market daily news